ALMS
2009
Aspreva Lupus Management Study
In 370 patients with active lupus nephritis, mycophenolate mofetil was non-inferior for induction response and superior for maintenance versus cyclophosphamide then azathioprine.
Result
Primary endpoint: Treatment response at 24 weeks; time to treatment failure
Induction response 56.2% MMF vs 53.0% IV cyclophosphamide; maintenance MMF vs azathioprine HR 0.44 for failure (p<0.001).
- Subtopic
- Lupus nephritis
- Design
- Open-label RCT (induction and maintenance phases)
- Relevance
- Important: one of several pillars.
- Source
- Appel GB, et al. J Am Soc Nephrol. 2009;20(5):1103-1112.doi 10.1681/ASN.2008101028
Discussion & critique
Made MMF an equivalent induction and superior maintenance agent; KDIGO 2024 prefers MMF with low-dose steroids.